Yale’s Saad Omer, director of the Yale Institute of Global Health and the associate dean at the Yale School of Medicine, has spent more than 20 years conducting research in countries throughout the world on ways to address vaccine hesitancy and increase vaccine uptake. In collaboration with Drs. Brita Roy, director of population health at Yale Medicine, and Kavin Patel, an infectious disease fellow, Dr. Omer has developed a CME module that provides an overview of evidence-based techniques to promote vaccine uptake.
during the early stages of the vaccine, Rollout vaccine demand outstripped vaccine supply, with many patients actively seeking vaccination, unable to be vaccinated as we have now reached the latter stages of the vaccine. Rollout vaccine supply has outstripped vaccine demand with many vaccine hesitant patients declining vaccine despite access learning effective ways to address this vaccine. Hesitancy is crucial for providers to promote vaccine uptake. While numerous entities have created talking points for providers on what to say, there exists a shortage of recommendations on effective messaging strategies focusing on how to say it. This module is responsive to that meat. The following are the objectives of this module. One discussed the projected rates of COVID-19 vaccine uptake and the reasons for vaccine hesitancy to describe evidenced based communication tools providers may use to promote covid 19 vaccine uptake. Three. Review the topics providers should be knowledgeable about when discussing the Covid 19 vaccine. The causes of vaccine. Hesitancy are complex and multifactorial and may include knowledge deficiency, attitudinal barriers and were conflicting beliefs among other variables. Many are grounded in values that patients have accumulated over a lifetime. For example, in the us vaccine, hesitancy surrounding COVID-19 is part of a much broader debate about the perceived conflict between personal liberties and the common good on the preference to avoid artificial vaccine products in exchange for natural immunity and a growing distress of the private enterprises regulatory bodies and public health institutions that make approve and promote vaccines, respectively. When such very drivers of vaccine hesitancy are at play. A static one size fits all vaccine campaign may not be the most effective approach. Instead, a dynamic approach focusing on the process of vaccine communication rather than the content of the vaccination campaign alone may be more effective as it allows the patient to set the agenda for the conversation, thus allowing the provider to address the specific concern underlying the vaccine. Hesitancy, in other words, when addressing the vaccine, hesitant patient, how we communicate is just as important as what we communicate
